Financials

News Ideas Technicals

4115 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SUNDER BIOMEDICAL TECH CO LTD operating, investing, and financing activities

4115 free cash flow for H2 23 is -6.54 M TWD. For 2023, 4115 free cash flow was -12.63 M TWD and operating cash flow was 47.54 M TWD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—